The latest issue of Advances in Pulmonary Hypertension addresses the effects of COVID-19 on pulmonary hypertension patients (PH) and the medical community. Advances is the Pulmonary Hypertension Association’s quarterly peer-reviewed clinical journal.
Volume 20, Issue 1, includes articles on:
- Health disparities that disproportionately affect COVID-19 in people with pulmonary arterial hypertension (PAH).
- PH and telehealth.
- Telehealth benefits and challenges for pediatric PH patients.
- COVID-19’s impact on PH clinical trials.
The issue addresses the unpredictable challenges that shaped 2020, editor Deborah Jo Levine, M.D., says. The issues “have transformed much of the way we all care for our patients, promote medical education and continue important clinical research,” writes Levine, director of pulmonary hypertension, University of Texas Health Science Center in San Antonio, Texas. “We have learned new strategies that have enabled us to continue and even improve our practices in ways that will be important for years to come.”
The articles show the PH community’s incredible work throughout the pandemic, says guest editor John J. Ryan, M.D., M.B., B.Ch., B.A.O. They capture the challenges the health care community faced in the past year and “demonstrate the agility of health care heroes in responding to crisis,” he writes in the Guest Editor’s Memo.
“We are excited to share them with our community as we continually work toward improving the lives of our patients with PH.”
Advances in Pulmonary Hypertension is available for free online. Register to be notified when future issues are published.
